Biodefense and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Biodefense Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biodefense Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biodefense Overall Market Size
2.1 Global Biodefense Market Size: 2022 VS 2029
2.2 Global Biodefense Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biodefense Players in Global Market
3.2 Top Global Biodefense Companies Ranked by Revenue
3.3 Global Biodefense Revenue by Companies
3.4 Top 3 and Top 5 Biodefense Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biodefense Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biodefense Players in Global Market
3.6.1 List of Global Tier 1 Biodefense Companies
3.6.2 List of Global Tier 2 and Tier 3 Biodefense Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biodefense Market Size Markets, 2022 & 2029
4.1.2 Anthrax
4.1.3 Smallpox
4.1.4 Botulism
4.1.5 Radiation/Nuclear
4.1.6 Others
4.2 By Type - Global Biodefense Revenue & Forecasts
4.2.1 By Type - Global Biodefense Revenue, 2018-2023
4.2.2 By Type - Global Biodefense Revenue, 2024-2029
4.2.3 By Type - Global Biodefense Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biodefense Market Size, 2022 & 2029
5.1.2 US Military Market
5.1.3 US Civilian Market
5.1.4 Non - US Market
5.2 By Application - Global Biodefense Revenue & Forecasts
5.2.1 By Application - Global Biodefense Revenue, 2018-2023
5.2.2 By Application - Global Biodefense Revenue, 2024-2029
5.2.3 By Application - Global Biodefense Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biodefense Market Size, 2022 & 2029
6.2 By Region - Global Biodefense Revenue & Forecasts
6.2.1 By Region - Global Biodefense Revenue, 2018-2023
6.2.2 By Region - Global Biodefense Revenue, 2024-2029
6.2.3 By Region - Global Biodefense Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biodefense Revenue, 2018-2029
6.3.2 US Biodefense Market Size, 2018-2029
6.3.3 Canada Biodefense Market Size, 2018-2029
6.3.4 Mexico Biodefense Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biodefense Revenue, 2018-2029
6.4.2 Germany Biodefense Market Size, 2018-2029
6.4.3 France Biodefense Market Size, 2018-2029
6.4.4 U.K. Biodefense Market Size, 2018-2029
6.4.5 Italy Biodefense Market Size, 2018-2029
6.4.6 Russia Biodefense Market Size, 2018-2029
6.4.7 Nordic Countries Biodefense Market Size, 2018-2029
6.4.8 Benelux Biodefense Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biodefense Revenue, 2018-2029
6.5.2 China Biodefense Market Size, 2018-2029
6.5.3 Japan Biodefense Market Size, 2018-2029
6.5.4 South Korea Biodefense Market Size, 2018-2029
6.5.5 Southeast Asia Biodefense Market Size, 2018-2029
6.5.6 India Biodefense Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biodefense Revenue, 2018-2029
6.6.2 Brazil Biodefense Market Size, 2018-2029
6.6.3 Argentina Biodefense Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biodefense Revenue, 2018-2029
6.7.2 Turkey Biodefense Market Size, 2018-2029
6.7.3 Israel Biodefense Market Size, 2018-2029
6.7.4 Saudi Arabia Biodefense Market Size, 2018-2029
6.7.5 UAE Biodefense Market Size, 2018-2029
7 Biodefense Companies Profiles
7.1 Emergent Biosolutions
7.1.1 Emergent Biosolutions Company Summary
7.1.2 Emergent Biosolutions Business Overview
7.1.3 Emergent Biosolutions Biodefense Major Product Offerings
7.1.4 Emergent Biosolutions Biodefense Revenue in Global Market (2018-2023)
7.1.5 Emergent Biosolutions Key News & Latest Developments
7.2 Hytest
7.2.1 Hytest Company Summary
7.2.2 Hytest Business Overview
7.2.3 Hytest Biodefense Major Product Offerings
7.2.4 Hytest Biodefense Revenue in Global Market (2018-2023)
7.2.5 Hytest Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Biodefense Major Product Offerings
7.3.4 GSK Biodefense Revenue in Global Market (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Biodefense Major Product Offerings
7.4.4 Sanofi Biodefense Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 PharmAthene
7.5.1 PharmAthene Company Summary
7.5.2 PharmAthene Business Overview
7.5.3 PharmAthene Biodefense Major Product Offerings
7.5.4 PharmAthene Biodefense Revenue in Global Market (2018-2023)
7.5.5 PharmAthene Key News & Latest Developments
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Company Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Biodefense Major Product Offerings
7.6.4 Bavarian Nordic Biodefense Revenue in Global Market (2018-2023)
7.6.5 Bavarian Nordic Key News & Latest Developments
7.7 SIGA Technologies
7.7.1 SIGA Technologies Company Summary
7.7.2 SIGA Technologies Business Overview
7.7.3 SIGA Technologies Biodefense Major Product Offerings
7.7.4 SIGA Technologies Biodefense Revenue in Global Market (2018-2023)
7.7.5 SIGA Technologies Key News & Latest Developments
7.8 Arbutus Biopharma
7.8.1 Arbutus Biopharma Company Summary
7.8.2 Arbutus Biopharma Business Overview
7.8.3 Arbutus Biopharma Biodefense Major Product Offerings
7.8.4 Arbutus Biopharma Biodefense Revenue in Global Market (2018-2023)
7.8.5 Arbutus Biopharma Key News & Latest Developments
7.9 DynPort Vaccine
7.9.1 DynPort Vaccine Company Summary
7.9.2 DynPort Vaccine Business Overview
7.9.3 DynPort Vaccine Biodefense Major Product Offerings
7.9.4 DynPort Vaccine Biodefense Revenue in Global Market (2018-2023)
7.9.5 DynPort Vaccine Key News & Latest Developments
7.10 Xoma Corporation
7.10.1 Xoma Corporation Company Summary
7.10.2 Xoma Corporation Business Overview
7.10.3 Xoma Corporation Biodefense Major Product Offerings
7.10.4 Xoma Corporation Biodefense Revenue in Global Market (2018-2023)
7.10.5 Xoma Corporation Key News & Latest Developments
7.11 Ichor Medical Systems
7.11.1 Ichor Medical Systems Company Summary
7.11.2 Ichor Medical Systems Business Overview
7.11.3 Ichor Medical Systems Biodefense Major Product Offerings
7.11.4 Ichor Medical Systems Biodefense Revenue in Global Market (2018-2023)
7.11.5 Ichor Medical Systems Key News & Latest Developments
7.12 Aeolus Pharmaceuticals
7.12.1 Aeolus Pharmaceuticals Company Summary
7.12.2 Aeolus Pharmaceuticals Business Overview
7.12.3 Aeolus Pharmaceuticals Biodefense Major Product Offerings
7.12.4 Aeolus Pharmaceuticals Biodefense Revenue in Global Market (2018-2023)
7.12.5 Aeolus Pharmaceuticals Key News & Latest Developments
7.13 Achaogen
7.13.1 Achaogen Company Summary
7.13.2 Achaogen Business Overview
7.13.3 Achaogen Biodefense Major Product Offerings
7.13.4 Achaogen Biodefense Revenue in Global Market (2018-2023)
7.13.5 Achaogen Key News & Latest Developments
7.14 Elusys Therapeutics
7.14.1 Elusys Therapeutics Company Summary
7.14.2 Elusys Therapeutics Business Overview
7.14.3 Elusys Therapeutics Biodefense Major Product Offerings
7.14.4 Elusys Therapeutics Biodefense Revenue in Global Market (2018-2023)
7.14.5 Elusys Therapeutics Key News & Latest Developments
7.15 Dynavax Technologies
7.15.1 Dynavax Technologies Company Summary
7.15.2 Dynavax Technologies Business Overview
7.15.3 Dynavax Technologies Biodefense Major Product Offerings
7.15.4 Dynavax Technologies Biodefense Revenue in Global Market (2018-2023)
7.15.5 Dynavax Technologies Key News & Latest Developments
7.16 Cleveland BioLabs
7.16.1 Cleveland BioLabs Company Summary
7.16.2 Cleveland BioLabs Business Overview
7.16.3 Cleveland BioLabs Biodefense Major Product Offerings
7.16.4 Cleveland BioLabs Biodefense Revenue in Global Market (2018-2023)
7.16.5 Cleveland BioLabs Key News & Latest Developments
7.17 Soligenix
7.17.1 Soligenix Company Summary
7.17.2 Soligenix Business Overview
7.17.3 Soligenix Biodefense Major Product Offerings
7.17.4 Soligenix Biodefense Revenue in Global Market (2018-2023)
7.17.5 Soligenix Key News & Latest Developments
7.18 Alnylam Pharmaceuticals
7.18.1 Alnylam Pharmaceuticals Company Summary
7.18.2 Alnylam Pharmaceuticals Business Overview
7.18.3 Alnylam Pharmaceuticals Biodefense Major Product Offerings
7.18.4 Alnylam Pharmaceuticals Biodefense Revenue in Global Market (2018-2023)
7.18.5 Alnylam Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biodefense Market Opportunities & Trends in Global Market
Table 2. Biodefense Market Drivers in Global Market
Table 3. Biodefense Market Restraints in Global Market
Table 4. Key Players of Biodefense in Global Market
Table 5. Top Biodefense Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biodefense Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biodefense Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biodefense Product Type
Table 9. List of Global Tier 1 Biodefense Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biodefense Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biodefense Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biodefense Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biodefense Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Biodefense Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biodefense Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biodefense Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Biodefense Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biodefense Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biodefense Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biodefense Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biodefense Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biodefense Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biodefense Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biodefense Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biodefense Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biodefense Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biodefense Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2024-2029
Table 30. Emergent Biosolutions Company Summary
Table 31. Emergent Biosolutions Biodefense Product Offerings
Table 32. Emergent Biosolutions Biodefense Revenue (US$, Mn) & (2018-2023)
Table 33. Emergent Biosolutions Key News & Latest Developments
Table 34. Hytest Company Summary
Table 35. Hytest Biodefense Product Offerings
Table 36. Hytest Biodefense Revenue (US$, Mn) & (2018-2023)
Table 37. Hytest Key News & Latest Developments
Table 38. GSK Company Summary
Table 39. GSK Biodefense Product Offerings
Table 40. GSK Biodefense Revenue (US$, Mn) & (2018-2023)
Table 41. GSK Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Biodefense Product Offerings
Table 44. Sanofi Biodefense Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. PharmAthene Company Summary
Table 47. PharmAthene Biodefense Product Offerings
Table 48. PharmAthene Biodefense Revenue (US$, Mn) & (2018-2023)
Table 49. PharmAthene Key News & Latest Developments
Table 50. Bavarian Nordic Company Summary
Table 51. Bavarian Nordic Biodefense Product Offerings
Table 52. Bavarian Nordic Biodefense Revenue (US$, Mn) & (2018-2023)
Table 53. Bavarian Nordic Key News & Latest Developments
Table 54. SIGA Technologies Company Summary
Table 55. SIGA Technologies Biodefense Product Offerings
Table 56. SIGA Technologies Biodefense Revenue (US$, Mn) & (2018-2023)
Table 57. SIGA Technologies Key News & Latest Developments
Table 58. Arbutus Biopharma Company Summary
Table 59. Arbutus Biopharma Biodefense Product Offerings
Table 60. Arbutus Biopharma Biodefense Revenue (US$, Mn) & (2018-2023)
Table 61. Arbutus Biopharma Key News & Latest Developments
Table 62. DynPort Vaccine Company Summary
Table 63. DynPort Vaccine Biodefense Product Offerings
Table 64. DynPort Vaccine Biodefense Revenue (US$, Mn) & (2018-2023)
Table 65. DynPort Vaccine Key News & Latest Developments
Table 66. Xoma Corporation Company Summary
Table 67. Xoma Corporation Biodefense Product Offerings
Table 68. Xoma Corporation Biodefense Revenue (US$, Mn) & (2018-2023)
Table 69. Xoma Corporation Key News & Latest Developments
Table 70. Ichor Medical Systems Company Summary
Table 71. Ichor Medical Systems Biodefense Product Offerings
Table 72. Ichor Medical Systems Biodefense Revenue (US$, Mn) & (2018-2023)
Table 73. Ichor Medical Systems Key News & Latest Developments
Table 74. Aeolus Pharmaceuticals Company Summary
Table 75. Aeolus Pharmaceuticals Biodefense Product Offerings
Table 76. Aeolus Pharmaceuticals Biodefense Revenue (US$, Mn) & (2018-2023)
Table 77. Aeolus Pharmaceuticals Key News & Latest Developments
Table 78. Achaogen Company Summary
Table 79. Achaogen Biodefense Product Offerings
Table 80. Achaogen Biodefense Revenue (US$, Mn) & (2018-2023)
Table 81. Achaogen Key News & Latest Developments
Table 82. Elusys Therapeutics Company Summary
Table 83. Elusys Therapeutics Biodefense Product Offerings
Table 84. Elusys Therapeutics Biodefense Revenue (US$, Mn) & (2018-2023)
Table 85. Elusys Therapeutics Key News & Latest Developments
Table 86. Dynavax Technologies Company Summary
Table 87. Dynavax Technologies Biodefense Product Offerings
Table 88. Dynavax Technologies Biodefense Revenue (US$, Mn) & (2018-2023)
Table 89. Dynavax Technologies Key News & Latest Developments
Table 90. Cleveland BioLabs Company Summary
Table 91. Cleveland BioLabs Biodefense Product Offerings
Table 92. Cleveland BioLabs Biodefense Revenue (US$, Mn) & (2018-2023)
Table 93. Cleveland BioLabs Key News & Latest Developments
Table 94. Soligenix Company Summary
Table 95. Soligenix Biodefense Product Offerings
Table 96. Soligenix Biodefense Revenue (US$, Mn) & (2018-2023)
Table 97. Soligenix Key News & Latest Developments
Table 98. Alnylam Pharmaceuticals Company Summary
Table 99. Alnylam Pharmaceuticals Biodefense Product Offerings
Table 100. Alnylam Pharmaceuticals Biodefense Revenue (US$, Mn) & (2018-2023)
Table 101. Alnylam Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Biodefense Segment by Type in 2022
Figure 2. Biodefense Segment by Application in 2022
Figure 3. Global Biodefense Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biodefense Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biodefense Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biodefense Revenue in 2022
Figure 8. By Type - Global Biodefense Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biodefense Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biodefense Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biodefense Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biodefense Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biodefense Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biodefense Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biodefense Revenue Market Share, 2018-2029
Figure 16. US Biodefense Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biodefense Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biodefense Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biodefense Revenue Market Share, 2018-2029
Figure 20. Germany Biodefense Revenue, (US$, Mn), 2018-2029
Figure 21. France Biodefense Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biodefense Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biodefense Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biodefense Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biodefense Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biodefense Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biodefense Revenue Market Share, 2018-2029
Figure 28. China Biodefense Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biodefense Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biodefense Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biodefense Revenue, (US$, Mn), 2018-2029
Figure 32. India Biodefense Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biodefense Revenue Market Share, 2018-2029
Figure 34. Brazil Biodefense Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biodefense Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biodefense Revenue Market Share, 2018-2029
Figure 37. Turkey Biodefense Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biodefense Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biodefense Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biodefense Revenue, (US$, Mn), 2018-2029
Figure 41. Emergent Biosolutions Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Hytest Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GSK Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PharmAthene Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bavarian Nordic Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. SIGA Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Arbutus Biopharma Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. DynPort Vaccine Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Xoma Corporation Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Ichor Medical Systems Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Aeolus Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Achaogen Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Elusys Therapeutics Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Dynavax Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Cleveland BioLabs Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Soligenix Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Alnylam Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
